Annual ROE
-312.38%
-147.06%-88.95%
31 December 2023
Summary:
Acurx Pharmaceuticals annual return on equity is currently -312.38%, with the most recent change of -147.06% (-88.95%) on 31 December 2023. During the last 3 years, it has fallen by -142.11% (-83.46%). ACXP annual ROE is now -204.11% below its all-time high of -102.72%, reached on 31 December 2021.ACXP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-392.34%
-21.14%-5.70%
30 September 2024
Summary:
Acurx Pharmaceuticals quarterly return on equity is currently -392.34%, with the most recent change of -21.14% (-5.70%) on 30 September 2024. Over the past year, it has dropped by -168.90% (-75.59%). ACXP quarterly ROE is now -272.10% below its all-time high of -105.44%, reached on 31 March 2022.ACXP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACXP ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -89.0% | -75.6% |
| 3 y3 years | -83.5% | -205.9% |
| 5 y5 years | - | - |
ACXP ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -204.1% | at low | -272.1% | at low |
| 5 y | 5 years | -204.1% | +56.8% | -272.1% | at low |
| alltime | all time | -204.1% | +56.8% | -272.1% | at low |
Acurx Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -392.34%(+5.7%) |
| June 2024 | - | -371.20%(+20.3%) |
| Mar 2024 | - | -308.46%(+6.5%) |
| Dec 2023 | -312.38%(+89.0%) | -289.68%(+29.6%) |
| Sept 2023 | - | -223.44%(+21.5%) |
| June 2023 | - | -183.88%(+16.3%) |
| Mar 2023 | - | -158.15%(+19.5%) |
| Dec 2022 | -165.32% | -132.33%(+20.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -110.06%(+1.1%) |
| June 2022 | - | -108.83%(+3.2%) |
| Mar 2022 | - | -105.44%(-7.6%) |
| Dec 2021 | -102.72%(-39.7%) | -114.12%(-11.0%) |
| Sept 2021 | - | -128.26%(+12.2%) |
| June 2021 | - | -114.32%(-38.3%) |
| Mar 2021 | - | -185.40%(+8.9%) |
| Dec 2020 | -170.27%(-76.5%) | -170.27% |
| Dec 2019 | -723.42% | - |
FAQ
- What is Acurx Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals annual ROE year-on-year change?
- What is Acurx Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals quarterly ROE year-on-year change?
What is Acurx Pharmaceuticals annual return on equity?
The current annual ROE of ACXP is -312.38%
What is the all time high annual ROE for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high annual return on equity is -102.72%
What is Acurx Pharmaceuticals annual ROE year-on-year change?
Over the past year, ACXP annual return on equity has changed by -147.06% (-88.95%)
What is Acurx Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ACXP is -392.34%
What is the all time high quarterly ROE for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high quarterly return on equity is -105.44%
What is Acurx Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ACXP quarterly return on equity has changed by -168.90% (-75.59%)